RESUMEN
Autosomal dominant retinal vasculopathy with cerebral leukodystrophy is a microvascular endotheliopathy with middle-age onset. In nine families, we identified heterozygous C-terminal frameshift mutations in TREX1, which encodes a 3'-5' exonuclease. These truncated proteins retain exonuclease activity but lose normal perinuclear localization. These data have implications for the maintenance of vascular integrity in the degenerative cerebral microangiopathies leading to stroke and dementias.
Asunto(s)
Encefalopatías/genética , Exodesoxirribonucleasas/genética , Mutación , Fosfoproteínas/genética , Enfermedades de la Retina/genética , Secuencia de Aminoácidos , Encefalopatías/enzimología , Línea Celular , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Exodesoxirribonucleasas/química , Exodesoxirribonucleasas/metabolismo , Genes Dominantes , Predisposición Genética a la Enfermedad , Humanos , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Microscopía Confocal , Datos de Secuencia Molecular , Fosfoproteínas/química , Fosfoproteínas/metabolismo , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Enfermedades de la Retina/enzimología , Homología de Secuencia de Aminoácido , TransfecciónRESUMEN
Familial hemiplegic migraine (FHM) is a severe subtype of migraine with hemiparesis during attacks. We scanned 10 families with FHM without mutations in the CACNA1A (FHM1) and ATP1A2 (FHM2) genes. We identified the novel p.L1649Q mutation (c.4946T>A) in Na(v)1.1 sodium channel gene SCN1A (FHM3) in a North American kindred with FHM without associated ataxia or epilepsy. Functional analysis of the mutation, introduced in the highly homologous human SCN5A, revealed markedly slowed inactivation and a two-fold faster recovery from fast inactivation predicting enhanced neuronal excitation. Our findings establish the role of neuronal Na(v)1.1 sodium channels in FHM and reinforce the involvement of ion channel dysfunction in the pathogenesis of this episodic brain disorder.
Asunto(s)
Epilepsia/genética , Trastornos Migrañosos/genética , Mutación , Proteínas del Tejido Nervioso/genética , Canales de Sodio/genética , Células Cultivadas , Tamización de Portadores Genéticos , Humanos , Mutagénesis , Canal de Sodio Activado por Voltaje NAV1.1 , Reacción en Cadena de la PolimerasaRESUMEN
Familial hemiplegic migraine (FHM) is a rare autosomal-dominant subtype of migraine with aura, associated with hemiparesis during the aura. Here we describe a unique FHM family in which two novel allelic missense mutations in the Na,K-ATPase gene ATP1A2 segregate in the proband with hemiplegic migraine. Both mutations show reduced penetrance in family members of the proband. Cellular survival assays revealed Na,K-ATPase dysfunction for both ATP1A2 mutants, indicating that both mutations are disease causative. This is the first case of compound heterozygosity for any of the known FHM genes.
Asunto(s)
Heterocigoto , Migraña con Aura/genética , ATPasa Intercambiadora de Sodio-Potasio/genética , Adolescente , Adulto , Secuencia de Aminoácidos , Niño , Femenino , Humanos , Masculino , Datos de Secuencia Molecular , LinajeRESUMEN
Familial hemiplegic migraine (FHM) is a rare autosomal dominantly inherited subtype of migraine, in which hemiparesis occurs during the aura. The majority of the families carry mutations in the CACNA1A gene on chromosome 19p13 (FHM1). About 20% of FHM families is linked to chromosome 1q23 (FHM2), and has mutations in the ATP1A2 gene, encoding the alpha2-subunit of the Na,K-ATPase. Mutation analysis in a Dutch and a Turkish family with pure FHM revealed two novel de novo missense mutations, R593W and V628M, respectively. Cellular survival assays support the hypothesis that both mutations are disease-causative. The identification of the first de novo mutations underscores beyond any doubt the involvement of the ATP1A2 gene in FHM2.
Asunto(s)
Hemiplejía/genética , Trastornos Migrañosos/genética , Mutación , ATPasa Intercambiadora de Sodio-Potasio/genética , Secuencia de Aminoácidos , Cromosomas Humanos Par 1 , Femenino , Células HeLa , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , ATPasa Intercambiadora de Sodio-Potasio/metabolismoRESUMEN
Familial hemiplegic migraine (FHM) is a rare autosomal dominant form of migraine with aura. This disease has been associated with missense mutations in the CACNA1A and ATP1A2 genes. The aim of this study was to identify whether CACNA1A and ATP1A2 are or not related to Brazilian FHM. Here we screened four Brazilian FHM families (total of 26 individuals--13 affected and 13 asymptomatic or normal) for mutations in both genes. We found an amino acid change in a member of family FHM-D (Arg2206Gly). However since this alteration is not present in all affected individuals and is present in one asymptomatic individual it should be considered a polymorphism. Further studies with additional families will be necessary to reveal the importance of both CACNA1A and ATP1A2 genes on the pathogeneses of FHM in Brazil and to test the third gene (SCN1A) in these FHM families.
Asunto(s)
Canales de Calcio/genética , Migraña con Aura/genética , Mutación/genética , Polimorfismo Genético/genética , ATPasa Intercambiadora de Sodio-Potasio/genética , Adulto , Brasil , Estudios de Casos y Controles , Niño , Femenino , Marcadores Genéticos/genética , Humanos , Masculino , Persona de Mediana Edad , LinajeAsunto(s)
Hemiplejía/genética , Trastornos Migrañosos/genética , Mutación/genética , Convulsiones Febriles/genética , ATPasa Intercambiadora de Sodio-Potasio/genética , Adolescente , Adulto , Preescolar , Comorbilidad , Análisis Mutacional de ADN , Epilepsia/genética , Familia , Femenino , Hemiplejía/epidemiología , Humanos , Masculino , Trastornos Migrañosos/epidemiología , Migraña con Aura/genética , Convulsiones Febriles/epidemiologíaRESUMEN
BACKGROUND: Episodic ataxia (EA) is variably associated with additional neurologic symptoms. At least 4 genes have been implicated. Recently, a mutation in the SLC1A3 gene encoding the glutamate transporter EAAT1 was identified in a patient with severe episodic and progressive ataxia, seizures, alternating hemiplegia, and migraine headache. The mutant EAAT1 showed severely reduced uptake of glutamate. The syndrome was designated EA6 and shares overlapping clinical features with EA2, which is caused by mutations in CACNA1A. OBJECTIVE: To test the role of the SLC1A3 gene in EA. DESIGN: Genetic and functional studies. We analyzed the coding region of the SLC1A3 gene by direct sequencing. SETTING: Academic research. PATIENTS: DNA samples from 20 patients with EA (with or without interictal nystagmus) negative for CACNA1A mutations were analyzed. MAIN OUTCOME MEASURES: We identified 1 novel EAAT1 mutation in a family with EA and studied the functional consequences of this mutation using glutamate uptake assay. RESULTS: We identified a missense C186S mutation that segregated with EA in 3 family members. The mutant EAAT1 showed a modest but significant reduction of glutamate uptake. CONCLUSIONS: We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia. The severity of EA6 symptoms appears to be correlated with the extent of glutamate transporter dysfunction.
Asunto(s)
Transportador 1 de Aminoácidos Excitadores/genética , Predisposición Genética a la Enfermedad/genética , Ácido Glutámico/metabolismo , Mutación/genética , Degeneraciones Espinocerebelosas/genética , Degeneraciones Espinocerebelosas/metabolismo , Adulto , Química Encefálica/genética , Cerebelo/metabolismo , Cerebelo/fisiopatología , Análisis Mutacional de ADN , Femenino , Marcadores Genéticos/genética , Pruebas Genéticas , Genotipo , Hemiplejía/genética , Hemiplejía/fisiopatología , Humanos , Patrón de Herencia/genética , Masculino , Persona de Mediana Edad , Trastornos Migrañosos/genética , Trastornos Migrañosos/fisiopatología , Linaje , Fenotipo , Convulsiones/genética , Convulsiones/fisiopatología , Degeneraciones Espinocerebelosas/fisiopatologíaRESUMEN
BACKGROUND: The 5-HT(1B/1D) receptor agonist sumatriptan is highly effective in the treatment of migraine. However, some patients do not respond to sumatriptan or experience recurrence of the headache after initial relief. In addition, some patients report chest symptoms after the use of sumatriptan. OBJECTIVE: To assess whether 2 genetic variants (F124C changing a phenylalanine for a cysteine and polymorphism A/T at nucleotide position -161 in the 5' regulatory region) of the 5-HT(1B) receptor play a major role in the therapeutic response to sumatriptan. The 5-HT(1B) receptor most likely mediates the therapeutic action and coronary side effects of sumatriptan, and both F124C and A-161T have relevant functional consequences on either the affinity of sumatriptan to bind to the 5-HT(1B) receptor or on receptor expression level itself, respectively. METHOD: Genomic DNA of a relatively small but very well-characterized set of migraine patients with consistently good response to sumatriptan (n = 14), with no response (n = 12), with recurrence of the headache (n = 12), with chest symptoms (n = 13), and patients without chest symptoms (n = 27) was available for the genetic analyses and screened for the F124C variant and the A-161T polymorphism in the human 5-HT(1B) receptor gene. RESULTS: F124C was not detected in any of the patients studied. In addition, we did not observe drastic changes in allele frequencies of the A-161T polymorphism that might hint to a causal relation with the therapeutic effect of sumatriptan. CONCLUSION: We have not obtained any evidence that variants F124C and A-161T of the 5-HT(1B) receptor are major determinants in the clinical response to sumatriptan.
Asunto(s)
Cisteína/genética , Variación Genética , Trastornos Migrañosos/genética , Fenilalanina/genética , Receptor de Serotonina 5-HT1B/genética , Adulto , Anciano , Análisis Mutacional de ADN , Femenino , Frecuencia de los Genes , Humanos , Masculino , Persona de Mediana Edad , Trastornos Migrañosos/tratamiento farmacológico , Farmacogenética , Agonistas de Receptores de Serotonina/uso terapéutico , Sumatriptán/uso terapéutico , Resultado del TratamientoRESUMEN
Familial hemiplegic migraine is a rare autosomal dominant subtype of migraine with aura. Three genes have been identified, all involved in ion transport. There is considerable clinical variation associated with FHM mutations. Genotype-phenotype correlation studies are needed, but are challenging mainly because the number of carriers of individual mutations is low. One exception is the recurrent T666M mutation in the FHM1 CACNA1A gene that was identified in almost one-third of FHM families and showed variable associated clinical features and severity, both within and among FHM families. Similar studies in the FHM2 ATP1A2 gene have not been performed because of the low number of carriers with individual mutations. Here we report on the recurrence of ATP1A2 mutations M731T and T376M that affect sodium-potassium pump functioning in two Portuguese FHM families. Considerably increasing the number of mutation carriers with these mutations indicated a clear genotype-phenotype correlation: both mutations are associated with pure FHM. In addition, we show that recurrent mutations for ATP1A2 are more frequent than previously thought, which has implications for genotype-phenotype correlations and genetic testing.
Asunto(s)
Migraña con Aura/genética , Mutación Missense , ATPasa Intercambiadora de Sodio-Potasio/genética , Anciano , Anciano de 80 o más Años , Salud de la Familia , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Migraña con Aura/epidemiología , Linaje , Fenotipo , Portugal/epidemiologíaRESUMEN
A growing interest in genetic research in migraine has resulted in the identification of several chromosomal regions that are involved in migraine. However, the identification of mutations in the genes for familial hemiplegic migraine (FHM) forms the only true molecular genetic knowledge of migraine thus far. The increased number of mutations in the FHM1 (CACNA1A) and the FHM2 (ATP1A2) genes allow studying the relationship between genetic findings in both genes and the clinical features in patients. A wide spectrum of symptoms is seen in patients. Additional cerebellar ataxia and (childhood) epilepsy can occur in FHM1 and FHM2. Functional studies show a dysfunction in ion transport as the key factor in the pathophysiology of (familial hemiplegic) migraine that predict an increased susceptibility to cortical spreading depression--the underlying mechanism of migraine aura.
Asunto(s)
Trastornos Migrañosos/genética , Animales , Canales de Calcio/genética , Humanos , Ratones , ATPasa Intercambiadora de Sodio-Potasio/genéticaRESUMEN
BACKGROUND: Familial hemiplegic migraine (FHM) is an autosomal dominant disorder, which can result from mutations in the CACNA1A (FHM1) and ATP1A2 (FHM2) genes. Typically, FHM presents with an aura of hemiplegia accompanied by a moderate-to-severe headache. FHM can be associated with other neurological findings including coma and seizures. METHODS: We describe the clinical and genetic features of a two-generation, seven-member Native Indian family with recurrent encephalopathy and FHM. RESULTS: Two of the three affected family members presented initially with encephalopathy, the third family member presented with classic episodes of migraine and hemiparesis. The CACNA1A gene locus was excluded in this family by haplotype analysis and no mutations were identified in the coding region of the ATP1A2 gene by direct sequencing. CONCLUSIONS: This emphasizes the genetic and clinical heterogeneity in familial hemiplagic migraine FHM and highlights the need to consider the diagnosis of FHM in cases of recurrent encephalopathy.
Asunto(s)
Encefalopatías/patología , Indígenas Norteamericanos/genética , Migraña con Aura/genética , Adulto , Encefalopatías/etiología , Canales de Calcio/genética , Niño , Análisis Mutacional de ADN , Femenino , Humanos , Masculino , Persona de Mediana Edad , Migraña con Aura/complicaciones , Linaje , Recurrencia , ATPasa Intercambiadora de Sodio-Potasio/genéticaRESUMEN
PURPOSE OF REVIEW: The progress in headache genetics, especially migraine genetics, recently jumped ahead with some major discoveries. RECENT FINDINGS: Family and epidemiological studies further strengthen the genetic contribution to migraine and two recent observations gave new molecular insights in the disease. Studies on the genetics of familial hemiplegic migraine revealed, in addition to the previously identified familial hemiplegic migraine type 1 gene CACNA1A on chromosome 19, the familial hemiplegic migraine type 2 gene ATP1A2, encoding the alpha2-subunit of sodium/potassium pumps. Recent genome screens in families with migraine identified susceptibility loci on chromosomes 4, 6, 11 and 14. SUMMARY: The findings in familial hemiplegic migraine confirm that dysfunction in ion transport is a key factor in migraine pathophysiology and might help us in the elucidation of migraine molecular pathways. The identification of several migraine susceptibility loci underline its genetically complex nature.
Asunto(s)
Trastornos Migrañosos/genética , Migraña con Aura/genética , Canales de Calcio/metabolismo , Canales de Calcio Tipo N , Canales de Calcio Tipo P , Canales de Calcio Tipo Q , Cromosomas Humanos Par 1 , Cromosomas Humanos Par 19 , Genes Dominantes , Ligamiento Genético , Predisposición Genética a la Enfermedad , Cefalea , Humanos , Trastornos Migrañosos/etiología , Migraña con Aura/diagnóstico , Migraña con Aura/fisiopatología , Modelos Genéticos , Mutación , ATPasa Intercambiadora de Sodio-Potasio/metabolismoRESUMEN
The genetics of migraine is a fascinating and rapidly moving research area. Familial hemiplegic migraine, a rare subtype of migraine with a Mendelian pattern of inheritance, is caused by mutations in the chromosome 19 CACNA1A gene or in the chromosome 1 ATP1A2 gene. Familial migraine variants are classified on the basis of clinical, descriptive criteria, but this is insufficient. In the future, a diagnostic classification based on mutation-analysis is needed.
Asunto(s)
Migraña con Aura/genética , Humanos , Migraña con Aura/clasificación , Migraña con Aura/diagnóstico , ATPasa Intercambiadora de Sodio-Potasio/genéticaRESUMEN
The transcriptional co-activator p63 is of crucial importance for correct development of the limbs, ectodermal appendages (skin, nails, teeth, hair, glands), lip and palate. Mutations in the p63 gene are found in a number of human syndromes, including ectrodactyly-ectodermal dysplasia-cleft lip/palate (EEC) syndrome, limb-mammary syndrome (LMS), Hay-Wells syndrome and in non-syndromic split-hand/split-foot malformation (SHFM). Each syndrome has a specific pattern of mutations with different functional effects in in vitro functional assays. We report a mutation R298Q in acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome, another EEC-like condition. The mutation is located in the DNA binding domain of p63, which harbors almost all EEC associated mutations. However, unlike mutations in EEC syndrome, the R298Q ADULT syndrome mutation does not impair DNA binding. Rather, the mutation confers novel transcription activation capacity on the DeltaN-p63gamma isoform, which normally does not possess such activity. These results confirm that ADULT syndrome is a clinically as well as molecularly distinct member of the expanding p63 mutation family of human malformation syndromes. Our results further show that p63 contains a second transactivation domain which is normally repressed and can become activated by mutations in the DNA binding domain of p63.
Asunto(s)
Anomalías Múltiples/genética , Proteínas de la Membrana , Fosfoproteínas/genética , Transactivadores/genética , Activación Transcripcional , Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Genes Supresores de Tumor , Humanos , Modelos Moleculares , Mutación Missense , Conformación Proteica , Estructura Terciaria de Proteína/genética , Síndrome , Factores de Transcripción , Proteínas Supresoras de TumorRESUMEN
Familial hemiplegic migraine (FHM) is a rare, severe, autosomal dominant subtype of migraine with aura. Up to 75% of FHM families have a mutation in the P/Q-type calcium channel Ca(v)2.1 subunit CACNA1A gene on chromosome 19p13. Some CACNA1A mutations also may cause epilepsy. Here, we describe novel missense mutations in the ATP1A2 Na(+),K(+)-ATPase pump gene on chromosome 1q23 in two families with FHM. The M731T mutation was found in a family with pure FHM. The R689Q mutation was identified in a family in which FHM and benign familial infantile convulsions partially cosegregate. In this family, all available affected family members with FHM, benign familial infantile convulsions, or both, carry the ATP1A2 mutation. Like FHM linked to 19p13, FHM linked to 1q23 also involves dysfunction of ion transportation and epilepsy is part of its phenotypic spectrum.
Asunto(s)
Epilepsia Benigna Neonatal/genética , Ligamiento Genético , Migraña con Aura/genética , ATPasa Intercambiadora de Sodio-Potasio/genética , Adolescente , Adulto , Anciano , Secuencia de Aminoácidos , Animales , Niño , Preescolar , Análisis Mutacional de ADN , Epilepsia Benigna Neonatal/complicaciones , Femenino , Haplotipos , Humanos , Masculino , Ratones , Persona de Mediana Edad , Migraña con Aura/complicaciones , Mutación Missense , Linaje , Reacción en Cadena de la Polimerasa , Ratas , Especificidad de la EspecieRESUMEN
Familial hemiplegic migraine (FHM) is a rare autosomal dominant form of migraine with aura. This disease has been associated with missense mutations in the CACNA1A and ATP1A2 genes. The aim of this study was to identify whether CACNA1A and ATP1A2 are or not related to Brazilian FHM. Here we screened four Brazilian FHM families (total of 26 individuals - 13 affected and 13 asymptomatic or normal) for mutations in both genes. We found an amino acid change in a member of family FHM-D (Arg2206Gly). However since this alteration is not present in all affected individuals and is present in one asymptomatic individual it should be considered a polymorphism. Further studies with additional families will be necessary to reveal the importance of both CACNA1A and ATP1A2 genes on the pathogeneses of FHM in Brazil and to test the third gene (SCN1A) in these FHM families.
A enxaqueca hemiplégica familial (EHF) é uma forma rara de enxaqueca com aura e apresenta herança autossômica dominante. Esta doença está associada com mutações do tipo missense nos genes CACNA1A e ATP1A2. O objetivo deste estudo foi identificar se os genes CACNA1A e ATP1A2 estão ou não relacionados com a enxaqueca hemiplégica familial em famílias brasileiras. Os genes citados acima foram analisados em quatro famílias brasileiras (total de 26 indivíduos - 13 afetados e 13 assintomáticos ou normais) e uma troca de aminoácido em um membro da família FHM-D (Arg2206Gly) foi observada. Porém, esta alteração não foi identificada em todos os indivíduos afetados e está presente em um indivíduo assintomático, devendo, portanto, ser considerada um polimorfismo. Estudos adicionais nas famílias já estudadas e em outras famílias brasileiras afetadas por enxaqueca hemiplégica familial serão necessários para esclarecer a importância dos genes CACNA1A e ATP1A2 na patogênese da EHF no Brasil, bem como para testar o terceiro gene (SCN1A) relacionado à EHF.